Roche Holding AG (GB:0QOK)
LSE:0QOK
Holding GB:0QOK?
Track your performance easily

Roche Holding AG (0QOK) Share Forecast & Price Target

31 Followers
See the Price Targets and Ratings of:

0QOK Analyst Ratings

Hold
14Ratings
4 Buy
6 Hold
4 Sell
Based on 14 analysts giving stock ratings to
Roche
Holding AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0QOK Stock 12 Month Forecast

Average Price Target

CHF286.60
▲(7.43% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF286.60 with a high forecast of CHF341.41 and a low forecast of CHF220.91. The average price target represents a 7.43% change from the last price of CHF266.76.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"216":"CHF216","279":"CHF279","342":"CHF342","247.5":"CHF247.5","310.5":"CHF310.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":341.408058000672,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF341.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":286.5957444,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF286.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":220.911096353376,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF220.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[216,247.5,279,310.5,342],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,271.7,277.06215830774397,282.424316615488,287.786474923232,293.148633230976,298.51079153872,303.872949846464,309.235108154208,314.597266461952,319.959424769696,325.32158307744,330.683741385184,336.045899692928,{"y":341.408058000672,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,271.7,272.8458264923077,273.99165298461537,275.1374794769231,276.28330596923075,277.4291324615385,278.57495895384614,279.72078544615385,280.8666119384615,282.01243843076924,283.1582649230769,284.3040914153846,285.4499179076923,{"y":286.5957444,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,271.7,267.79316125795197,263.886322515904,259.979483773856,256.072645031808,252.16580628975998,248.258967547712,244.352128805664,240.445290063616,236.538451321568,232.63161257951998,228.724773837472,224.817935095424,{"y":220.911096353376,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":228.408,"date":1698969600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":229.816,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":241.939,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":225.751,"date":1706832000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":225.061,"date":1709251200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":220.668,"date":1712275200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":217.3,"date":1714694400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":243.181,"date":1717718400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":243.449,"date":1720137600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":285.8,"date":1722556800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":274.64,"date":1725580800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":259.006,"date":1728000000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":271.7,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF341.41Average Price TargetCHF286.60Lowest Price TargetCHF220.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
CHF320CHF315
Hold
18.08%
Upside
Reiterated
10/01/24
Hold Rating Maintained for Roche Amid Awaited Clinical Readouts and Steady Growth in Diagnostics
Bank of America Securities
CHF340
Buy
27.45%
Upside
Upgraded
09/13/24
Roche Holding AG: A Turnaround in EPS and Promising Pipeline Justify Buy Rating
Bernstein
CHF305CHF340
Buy
27.45%
Upside
Reiterated
08/29/24
Roche Holding AG: A Promising Buy Rating with Strong Financial Prospects and Innovative Pipeline
Morgan Stanley
CHF260CHF280
Sell
4.96%
Upside
Reiterated
08/09/24
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), GoodRx Holdings (NASDAQ: GDRX) and Tenaya Therapeutics (NASDAQ: TNYA)
Citi
CHF335
Buy
25.58%
Upside
Reiterated
06/24/24
Citi Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

Best Analysts Covering Roche Holding AG

Which Analyst Should I Follow If I Want to Buy GB:0QOK and Sell After:
1 Month
xxx
Success Rate
13/17 ratings generated profit
76%
Average Return
+0.70%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 76.47% of your transactions generating a profit, with an average return of +0.70% per trade.
3 Months
xxx
Success Rate
32/42 ratings generated profit
76%
Average Return
+2.73%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.19% of your transactions generating a profit, with an average return of +2.73% per trade.
1 Year
Richard VosserJ.P. Morgan
Success Rate
28/42 ratings generated profit
67%
Average Return
+5.95%
reiterated a sell rating 17 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.95% per trade.
2 Years
xxx
Success Rate
35/48 ratings generated profit
73%
Average Return
+8.40%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 72.92% of your transactions generating a profit, with an average return of +8.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QOK Analyst Recommendation Trends

Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
12
8
9
7
7
Hold
29
25
27
22
21
Sell
13
13
18
16
14
Strong Sell
0
0
0
0
0
total
54
46
54
45
42
In the current month, 0QOK has received 7 Buy Ratings, 21 Hold Ratings, and 14 Sell Ratings. 0QOK average Analyst price target in the past 3 months is CHF286.60.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

0QOK Financial Forecast

0QOK Earnings Forecast

Next quarter’s earnings estimate for 0QOK is CHF8.39 with a range of CHF8.15 to CHF8.72. The previous quarter’s EPS was CHF10.23. 0QOK beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.00% of the time in the same period. In the last calendar year 0QOK has Outperformed its overall industry.
Next quarter’s earnings estimate for 0QOK is CHF8.39 with a range of CHF8.15 to CHF8.72. The previous quarter’s EPS was CHF10.23. 0QOK beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.00% of the time in the same period. In the last calendar year 0QOK has Outperformed its overall industry.

0QOK Sales Forecast

Next quarter’s sales forecast for 0QOK is CHF15.35B with a range of CHF15.07B to CHF15.57B. The previous quarter’s sales results were CHF29.85B. 0QOK beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 44.74% of the time in the same period. In the last calendar year 0QOK has Outperformed its overall industry.
Next quarter’s sales forecast for 0QOK is CHF15.35B with a range of CHF15.07B to CHF15.57B. The previous quarter’s sales results were CHF29.85B. 0QOK beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 44.74% of the time in the same period. In the last calendar year 0QOK has Outperformed its overall industry.

0QOK Stock Forecast FAQ

What is GB:0QOK’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding AG’s 12-month average price target is CHF286.60.
    What is GB:0QOK’s upside potential, based on the analysts’ average price target?
    Roche Holding AG has 7.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Roche Holding AG a Buy, Sell or Hold?
          Roche Holding AG has a consensus rating of Hold, which is based on 4 buy ratings, 6 hold ratings and 4 sell ratings.
            What is Roche Holding AG’s share price target?
            The average share price target for Roche Holding AG is CHF286.60. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF341.41 ,and the lowest forecast is CHF220.91. The average share price target represents 7.43% Increase from the current price of CHF266.762.
              What do analysts say about Roche Holding AG?
              Roche Holding AG’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of Roche Holding AG?
                To buy shares of GB:0QOK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis